Ruggero Fariello
Corporate Officer/Principal chez SeneXta Therapeutics SA
Postes actifs de Ruggero Fariello
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
SeneXta Therapeutics SA
 SeneXta Therapeutics SA Medical SpecialtiesHealth Technology SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland. | Corporate Officer/Principal | 18/09/2009 | - |
Historique de carrière de Ruggero Fariello
Anciens postes connus de Ruggero Fariello
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Directeur/Membre du Conseil | 01/01/1999 | 21/05/2007 |
| Fondateur | 01/01/1999 | 21/05/2007 | |
| Independent Dir/Board Member | 01/01/1999 | 21/05/2007 | |
Neurotune AG
 Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Directeur Technique/Scientifique/R&D | 04/11/2009 | 20/02/2013 |
| Corporate Officer/Principal | 20/02/2013 | - | |
| Thomas Jefferson University | Directeur Technique/Scientifique/R&D | 18/09/2009 | - |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - | - |
CNS, Inc. (Delaware)
 CNS, Inc. (Delaware) Food RetailRetail Trade CNS, Inc. manufactures pharmaceutical products and health supplements. It markets the products as a treatment for allergies, snoring, and general nasal congestion. The company also sells FiberChoice, a chewable fiber supplement and a Breathe Right-branded throat rinse for snorers. It was founded in 1982 and is headquartered in Minneapolis, MN. | Directeur Technique/Scientifique/R&D | - | - |
| Rush University | Président | - | - |
Formation de Ruggero Fariello
| University of Turin | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Suisse | 3 |
| Italie | 3 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chairman | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 4 |
| Retail Trade | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Health Technology |
| Entreprise privées | 4 |
|---|---|
SeneXta Therapeutics SA
SeneXta Therapeutics SA Medical SpecialtiesHealth Technology SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland. | Health Technology |
CNS, Inc. (Delaware)
CNS, Inc. (Delaware) Food RetailRetail Trade CNS, Inc. manufactures pharmaceutical products and health supplements. It markets the products as a treatment for allergies, snoring, and general nasal congestion. The company also sells FiberChoice, a chewable fiber supplement and a Breathe Right-branded throat rinse for snorers. It was founded in 1982 and is headquartered in Minneapolis, MN. | Retail Trade |
| Pharmacia & Upjohn, Inc. | Health Technology |
Neurotune AG
Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Health Technology |
- Bourse
- Insiders
- Ruggero Fariello
- Expérience
